BR112013020005A8 - peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica - Google Patents
peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêuticaInfo
- Publication number
- BR112013020005A8 BR112013020005A8 BR112013020005A BR112013020005A BR112013020005A8 BR 112013020005 A8 BR112013020005 A8 BR 112013020005A8 BR 112013020005 A BR112013020005 A BR 112013020005A BR 112013020005 A BR112013020005 A BR 112013020005A BR 112013020005 A8 BR112013020005 A8 BR 112013020005A8
- Authority
- BR
- Brazil
- Prior art keywords
- stereoisomers
- cosmetic
- acceptable salts
- pharmaceutically
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Birds (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica trata-se de peptídeos de fórmula geral (i): r~1~ - w~n~ - x~m~ -aa~1~ - aa~2~ - aa~3~ - aa~4~ - aa~5~ - aa~6~ - y~p~ - z~q~ - r~2~ (i) seus estereoisômeros, misturadas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis, um processo de preparação, composições cosméticas ou farmacêuticas que contêm os mesmos e seu uso para o tratamento e/ou cuidade de distúrbios e/ou doenças da pele e/ou membranas mucosas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161467643P | 2011-03-25 | 2011-03-25 | |
ES201130441A ES2397890B1 (es) | 2011-03-25 | 2011-03-25 | Péptidos útiles en el tratamiento y/o cuidado de la piel y/o mucosas y su uso en composiciones cosméticas o farmacéuticas. |
PCT/EP2012/055250 WO2012130771A1 (en) | 2011-03-25 | 2012-03-23 | Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013020005A2 BR112013020005A2 (pt) | 2017-10-31 |
BR112013020005A8 true BR112013020005A8 (pt) | 2018-01-09 |
Family
ID=46929507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013020005A BR112013020005A8 (pt) | 2011-03-25 | 2012-03-23 | peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica |
Country Status (9)
Country | Link |
---|---|
US (1) | US9067967B2 (pt) |
EP (1) | EP2651963B1 (pt) |
JP (1) | JP6075650B2 (pt) |
KR (1) | KR101988675B1 (pt) |
CN (1) | CN103314005B (pt) |
AU (1) | AU2012234366B2 (pt) |
BR (1) | BR112013020005A8 (pt) |
ES (2) | ES2397890B1 (pt) |
WO (1) | WO2012130771A1 (pt) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11389663B2 (en) | 2011-04-01 | 2022-07-19 | Bioregentech, Inc. | Laser assisted wound healing protocol and system |
US11730760B2 (en) | 2011-04-01 | 2023-08-22 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
JP6399561B2 (ja) * | 2013-04-16 | 2018-10-03 | モレキュラー システムズ, リミテッドMolecular Systems, Ltd. | レーザアシストの歯周組織と骨再生法 |
US20160000858A1 (en) * | 2014-07-07 | 2016-01-07 | Gojo Industries, Inc. | Compositions and methods for mitigating skin irritation and enhancing skin barrier function |
US10242871B2 (en) * | 2014-10-21 | 2019-03-26 | Nissan Chemical Industries, Ltd. | Resist underlayer film-forming composition including a compound having an amino group protected with a tert-butoxycarbonyl group |
US10905646B2 (en) | 2014-10-31 | 2021-02-02 | Lubrizol Advanced Materials, Inc. | Thermoplastic polyurethane film for delivery of active agents to skin surfaces |
CN104622779A (zh) * | 2015-01-08 | 2015-05-20 | 上海圣婕化妆品有限公司 | 一种多胜肽抗衰老修复面膜精华液及其制备方法 |
CN104523449A (zh) * | 2015-01-08 | 2015-04-22 | 上海圣婕化妆品有限公司 | 一种抗衰老多胜肽复合物及其应用 |
WO2016138294A1 (en) * | 2015-02-25 | 2016-09-01 | The Regents Of The University Of California | Hesperidin-containing compositions and methods for treatment of skin disorders |
CA2980759A1 (en) | 2015-03-31 | 2016-10-06 | Gojo Industries, Inc. | Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function |
EP3117830A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Antibacterial peptides, and uses thereof |
EP3118215A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Anti-inflammatory peptides, and uses thereof |
EP3117831A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Peptides for use in promoting transport of glucose into skeletal muscle |
KR20230132623A (ko) | 2015-07-16 | 2023-09-15 | 뉴리타스 리미티드 | 항염증 펩티드, 및 그의 용도 |
EP3118216A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Cellular growth and proliferation promoting peptides, and uses thereof |
CN104997693A (zh) * | 2015-07-31 | 2015-10-28 | 魏善众 | 植物甾醇酯化妆品 |
CN105039030A (zh) * | 2015-08-06 | 2015-11-11 | 吴敏 | 一种预防妊娠纹的香皂及其制备方法 |
US20180311358A1 (en) | 2015-11-05 | 2018-11-01 | Lubrizol Advanced Materials, Inc. | Thermoformable dual network hydrogel compositions |
KR101686399B1 (ko) * | 2015-11-26 | 2016-12-15 | 코스맥스 유에스에이, 코퍼레이션 | 항노화용 화장료 조성물 |
US10799442B2 (en) | 2015-12-10 | 2020-10-13 | Lubrizol Advanced Materials, Inc. | Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes |
CN108883048A (zh) | 2016-02-04 | 2018-11-23 | 阿拉斯廷护肤公司 | 用于侵入性和非侵入性程序性护肤的组合物和方法 |
US10493020B2 (en) | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
US9872523B2 (en) * | 2016-05-13 | 2018-01-23 | Elvis Salkovic | Piece of clothing for supporting sleep |
WO2018014936A1 (en) * | 2016-07-18 | 2018-01-25 | Nuritas Limited | Topical compositions |
US11654293B2 (en) | 2016-11-10 | 2023-05-23 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
WO2018089954A1 (en) | 2016-11-10 | 2018-05-17 | BioRegentech | Laser assisted wound healing protocol and system |
CN110381976A (zh) * | 2016-12-05 | 2019-10-25 | 努里塔斯有限公司 | 包括肽wkdeagkplvk的组合物 |
EP3329930A1 (en) | 2016-12-05 | 2018-06-06 | Nuritas Limited | Pharmaceuctical compositions |
EP3329905A1 (en) * | 2016-12-05 | 2018-06-06 | Nuritas Limited | Topical cosmetic compositions comprising an oligopeptide against anti-aging of the skin |
CN106667788A (zh) * | 2017-02-08 | 2017-05-17 | 广东科玮生物技术股份有限公司 | 一种含生长因子的面膜液及干式面膜 |
KR102087123B1 (ko) | 2017-04-21 | 2020-03-10 | 유씨엘 주식회사 | 펩타이드와 해조류 추출물을 함유하는 나노에멀젼 및 그를 이용한 화장료 조성물 |
EP3648784B1 (en) * | 2017-07-04 | 2021-12-22 | Lubrizol Advanced Materials, Inc. | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes |
US10493011B2 (en) | 2017-08-03 | 2019-12-03 | ALASTIN Skincare, Inc. | Peptide compositions and methods for ameliorating skin laxity and body contour |
CN107365355B (zh) * | 2017-08-07 | 2020-06-26 | 温州千瑞生物科技有限公司 | 抗皱纹的肽以及包含其的化妆品 |
CN107778349B (zh) * | 2017-11-29 | 2021-05-04 | 陕西慧康生物科技有限责任公司 | 一种合成ghk醋酸盐的方法 |
KR102038366B1 (ko) * | 2018-05-29 | 2019-10-30 | 주식회사 조인앤믹스 | 여드름 피부 개선용 화장료 조성물 |
US10980851B2 (en) * | 2018-06-08 | 2021-04-20 | The Procter & Gamble Company | Topical skincare compositions comprising Centella asiatica selected triterpenes |
US20210238229A1 (en) | 2018-06-14 | 2021-08-05 | University College Cork - National University Of Ireland, Cork | Peptide for disease treatment |
CN110652578A (zh) * | 2018-06-29 | 2020-01-07 | 重庆合钰成贸易有限公司 | 女性舒柔养护凝胶及其制备方法 |
CN112367968B (zh) * | 2018-07-06 | 2023-06-16 | 安医健有限公司 | 包含肽复合物作为有效成分的用于去除或吸附微尘的化妆品组合物 |
US11103455B2 (en) | 2018-08-02 | 2021-08-31 | ALASTIN Skincare, Inc. | Liposomal compositions and methods of use |
CN109010113B (zh) * | 2018-08-28 | 2021-08-17 | 高宝化妆品(中国)有限公司 | 一种修复敏感肌肤的组合物及其应用 |
CN109431914B (zh) * | 2018-12-27 | 2020-07-07 | 湖南御家化妆品制造有限公司 | 头皮养护组合物及其应用 |
KR20220007875A (ko) * | 2019-05-08 | 2022-01-19 | 앨러스틴 스킨케어, 인크. | 멍듬 개선 및 피부를 젊어지게 하기 위한 조성물 및 방법 |
EP3990124A1 (en) * | 2019-06-28 | 2022-05-04 | L'Oréal | Anti-aging compositions and skin masks containing anti-aging compositions |
EP3783012A1 (en) | 2019-08-20 | 2021-02-24 | Nuritas Limited | An antimicrobial peptide |
JP2022545265A (ja) | 2019-08-20 | 2022-10-26 | ニューリタス リミテッド | 筋萎縮を治療するためのペプチド |
AU2020370733A1 (en) | 2019-10-22 | 2022-05-05 | Nuritas Limited | Treatment of non-alcoholic fatty liver disease |
US20230000759A1 (en) * | 2019-12-30 | 2023-01-05 | Rodan & Fields, Llc | Ppar agonist complex and methods of use |
EP3862014A1 (en) | 2020-02-07 | 2021-08-11 | Nuritas Limited | Treatment of panx1 associated diseases |
CN111909243B (zh) * | 2020-08-04 | 2022-01-18 | 立康荣健(北京)生物医药科技有限公司 | 一种抗菌肽和抗菌止痒药物组合物及应用 |
US20230320967A1 (en) * | 2020-09-11 | 2023-10-12 | Chemyunion Ltda. | Composition, use of the composition, cosmetic method for modulating the production of sebum |
EP4281034A1 (en) | 2021-01-24 | 2023-11-29 | Forrest, Michael, David | Inhibitors of atp synthase - cosmetic and therapeutic uses |
US20240197827A1 (en) | 2021-04-14 | 2024-06-20 | University College Cork - National University Of Ireland, Cork | Psg1 for use in the treatment of osteoarthritis |
JP2024514195A (ja) | 2021-04-14 | 2024-03-28 | ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク | 脳血管イベントおよび神経障害の治療 |
CN113750216B (zh) * | 2021-10-22 | 2022-10-25 | 北美生命科学(上海)有限公司 | 一种抗衰老的化妆品或药物 |
CN114315968B (zh) * | 2021-12-31 | 2022-10-18 | 深圳市维琪医药研发有限公司 | 一种九肽及其美容组合物或药用组合物和用途 |
CN115192471B (zh) * | 2022-07-13 | 2023-07-18 | 海南省麦吉丽生物科技有限公司 | 一种可以改善皮肤弹性的纳米乳凝胶、化妆品组合物及其制备和应用 |
WO2024078729A1 (en) | 2022-10-14 | 2024-04-18 | University College Cork - National University Of Ireland, Cork | Placenta expressed proteins for use in the treatment of tendon injury |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2695035A1 (fr) | 1992-08-25 | 1994-03-04 | Lvmh Rech Gie | Utilisation d'un ecdystéroïde pour la préparation de compositions cosmétiques ou dermatologiques destinées notamment à renforcer la fonction protectrice de la peau, et compositions ainsi obtenues. |
FR2801504B1 (fr) | 1999-11-26 | 2002-02-15 | Lvmh Rech | Extrait d'ajuga turkestanica et ses applications cosmetiques |
FR2831058B1 (fr) | 2001-10-18 | 2004-01-16 | Jean Noel Thorel | Composition cosmetique hydratante comprenant des aquaporines |
ATE510852T1 (de) * | 2001-10-30 | 2011-06-15 | Dsm Ip Assets Bv | Dermopharmazeutisch und kosmetisch wirksame oligopeptide |
JP2004168732A (ja) | 2002-11-22 | 2004-06-17 | Kanebo Ltd | 活性酸素消去剤、ヒアルロン酸合成促進・分解抑制剤およびアクアポリン合成促進剤 |
FR2854897B1 (fr) * | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
ES2293753B1 (es) * | 2004-04-28 | 2009-03-16 | Lipotec, S.A. | Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular. |
JP2005343882A (ja) | 2004-06-07 | 2005-12-15 | Kanebo Cosmetics Inc | ヒアルロン酸産生促進剤、アクアポリン合成促進剤、及び皮膚外用剤組成物 |
JP2006290873A (ja) | 2005-03-14 | 2006-10-26 | Rohto Pharmaceut Co Ltd | アクアポリン発現促進剤 |
WO2006113681A2 (en) | 2005-04-15 | 2006-10-26 | Human Matrix Sciences, Llc | Plant-derived elastin binding protein ligands and methods of using the same |
JP2009500394A (ja) | 2005-07-08 | 2009-01-08 | ザ プロクター アンド ギャンブル カンパニー | パーソナルケア組成物及び哺乳類の皮膚と毛髪を美化する方法 |
FR2889949B1 (fr) | 2005-08-26 | 2014-01-10 | Jean Noel Thorel | Utilisation d'un actif cosmetique et/ou dermocosmetique a base d'extrait vegetal de pyrus malus |
WO2007124991A1 (de) | 2006-04-27 | 2007-11-08 | Beiersdorf Ag | Kosmetische zubereitung mit aquaporin-stimulatoren und deren verwendung |
FR2903015B1 (fr) | 2006-06-30 | 2012-07-20 | Courtage Et De Diffusion Codif Internat Soc D | Utilisation d'au moins un extrait d'une algue brune et/ou d'une plante halophyte pour la realisation de compositions cosmetiques. |
KR20080024868A (ko) | 2006-09-15 | 2008-03-19 | 전남대학교산학협력단 | 수분채널단백질인 아쿠아포린 및 이를 조절하는 여성의 질윤활제 |
DE102007024384A1 (de) | 2007-05-23 | 2008-11-27 | Henkel Ag & Co. Kgaa | Kosmetische und dermatologische Zusammensetzungen gegen trockene Haut |
FR2925501B1 (fr) | 2007-12-21 | 2012-12-14 | Vincience | Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant |
FR2925500B1 (fr) | 2007-12-21 | 2011-05-06 | Vincience | Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant |
WO2009106934A1 (en) | 2008-02-29 | 2009-09-03 | Chemyunion Química Ltda | Angico-branco (piptadenia colubrina) extracts for use in cosmetic and dermatological formulations |
ES2330291B1 (es) * | 2008-02-29 | 2010-10-18 | Lipotec Sa | Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. |
FR2928090B1 (fr) | 2008-03-03 | 2014-10-10 | Lvmh Rech | Utilisation d'un extrait de l'orchidee vanda coerulea comme agent hydratant de la peau |
FR2941232B1 (fr) | 2009-01-16 | 2014-08-08 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
ES2349972B1 (es) * | 2009-02-16 | 2011-11-24 | Lipotec, S.A. | Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosméticas o farmacéuticas. |
AU2010237349B2 (en) * | 2009-04-17 | 2014-05-29 | Lipotec S.A. | Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
FR2954697B1 (fr) * | 2009-12-24 | 2016-11-04 | Isp Investments Inc | Composition cosmetique et/ou pharmaceutique comprenant un extrait de caroube en tant qu'agent actif activateur de l'expression des aquaporines |
-
2011
- 2011-03-25 ES ES201130441A patent/ES2397890B1/es active Active
-
2012
- 2012-03-23 AU AU2012234366A patent/AU2012234366B2/en active Active
- 2012-03-23 ES ES12711623T patent/ES2572260T3/es active Active
- 2012-03-23 EP EP12711623.4A patent/EP2651963B1/en active Active
- 2012-03-23 WO PCT/EP2012/055250 patent/WO2012130771A1/en active Application Filing
- 2012-03-23 BR BR112013020005A patent/BR112013020005A8/pt not_active IP Right Cessation
- 2012-03-23 CN CN201280004968.0A patent/CN103314005B/zh active Active
- 2012-03-23 KR KR1020137027963A patent/KR101988675B1/ko active IP Right Grant
- 2012-03-23 US US14/007,072 patent/US9067967B2/en active Active
- 2012-03-23 JP JP2014500416A patent/JP6075650B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
AU2012234366B2 (en) | 2017-04-13 |
EP2651963B1 (en) | 2016-03-23 |
AU2012234366A1 (en) | 2013-07-18 |
US9067967B2 (en) | 2015-06-30 |
KR20140043727A (ko) | 2014-04-10 |
JP2014510090A (ja) | 2014-04-24 |
ES2397890A1 (es) | 2013-03-12 |
JP6075650B2 (ja) | 2017-02-08 |
CN103314005A (zh) | 2013-09-18 |
ES2572260T3 (es) | 2016-05-31 |
ES2397890B1 (es) | 2014-02-07 |
WO2012130771A1 (en) | 2012-10-04 |
KR101988675B1 (ko) | 2019-06-12 |
BR112013020005A2 (pt) | 2017-10-31 |
CN103314005B (zh) | 2016-08-10 |
US20140120141A1 (en) | 2014-05-01 |
EP2651963A1 (en) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013020005A2 (pt) | peptídeo de fórmula geral r1-wn-xm-aa1-aa2-aa3-aa4-aa5-aa6-yp-zq-r2, seus estereoisômeros, misturas dos mesmos e/ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica | |
BRPI0913831B8 (pt) | peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis, processo para a preparação de um peptídeo com a fórmula geral (i), seus estereoisômeros, suas misturas, ou seus sais cosmética ou farmaceuticamente aceitáveis e composição cosmética ou farmacêutica | |
BR112018011643A2 (pt) | composto, composição cosmética ou farmacêutica, uso de um composto, e, método para tratamento e/ou cuidado não terapêutico e cosmético da pele, cabelo, unhas e/ou membranas mucosas. | |
MX2011008616A (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel , mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas. | |
MX337830B (es) | Peptidos utiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosmeticas o farmaceuticas. | |
TW201129368A (en) | Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions | |
BR112015012565A2 (pt) | composto, composição cosmética ou farmacêutica, e, uso de um composto | |
BRPI0906064B8 (pt) | peptídeo, processo para obtenção de um peptídeo de fórmula geral (i), composição cosmética ou farmacêutica e uso de um peptídeo de fórmula geral (i) | |
BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
BR112014028633A8 (pt) | tratamento de amd usando sflt-1 de aav | |
ES2397889A1 (es) | PÉPTIDOS MODULADORES DE PGC-1Alfa. | |
BR112014009851A2 (pt) | moduladores de receptor de nmda e usos dos mesmos | |
BR112015025961A2 (pt) | composto, composição cosmética ou farmacêutica, e, uso de um composto | |
BR112015014458A8 (pt) | compostos derivados de manose, seus intermediários, composição, uso e processos de preparação | |
BRPI0513819A (pt) | inibidores de hsp90 | |
BR112015017997A8 (pt) | amidas de quinolina e quinoxalina como moduladores de canais de sódio, composição farmacêutica que as compreende e uso | |
BR112015027282A8 (pt) | formulação líquida e kit compreendendo fenfluramina, e usos da mesma no tratamento de síndrome de dravet | |
BR112015007366A2 (pt) | derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças | |
BR112012029959A2 (pt) | compostos de carbamato de mentila como ativos para clareamento de pele e/ou cabelo | |
BR112013031510A2 (pt) | [1,3]oxazinas | |
ECSP045140A (es) | Formulaciones farmacéuticas derivadas del platino | |
BR112014031731A2 (pt) | entidades químicas, composições farmacêuticas, usos de entidades químicas ou de composições, compostos ou sais farmaceuticamente aceitáveis dos mesmos e métodos para tratar doenças, distúrbios ou condições médicas mediadas pela atividade enzimática pde1 e para modular a atividade da enzima pde1 | |
BRPI0519280A2 (pt) | composto, composiÇço farmacÊutica e uso de um composto | |
BR112014015482A8 (pt) | compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática | |
MX356343B (es) | Compuestos que inhiben la exocitosis neuronal (ii). |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2559 DE 2020-01-21 |